Sign In
Buy AYLA
$0.504
+0 (+0%)
At Close: Apr 17, 2023
Ayala Pharmaceuticals Announces Closing of Initial Public Offering
08:01pm, Tuesday, 12'th May 2020
REHOVOT, Israel & WILMINGTON, Del., May 12, 2020 -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing.
Ayala Pharmaceuticals Announces Pricing of Initial Public Offering
10:58pm, Thursday, 07'th May 2020
Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive canc
